Locoregional treatment of breast cancer during pregnancy

Gynecological Surgery

Volumn 11, Issue 4, 2014, Pages 279-284

  Toesca, Antonio ^a   Gentilini, Oreste ^a   Peccatori, Fedro ^a   Azim, Hatem A ^b   Amant, Frederic ^c  

^a EUROPEAN INSTITUTE OF ONCOLOGY   (Italy)

^b JULES BORDET INSTITUTE   (Belgium)

^c UNIVERSITY OF LEUVEN   (Belgium)

Author keywords

Breast cancer; Chemotherapy; Pregnancy; Radiation therapy

Indexed keywords

TECHNETIUM 99M;

ACCELERATED PARTIAL BREAST IRRADIATION; AWARENESS; BREAST CANCER; BREAST CANCER DURING PREGNANCY; BREAST RECONSTRUCTION; CANCER ADJUVANT THERAPY; CANCER PROGNOSIS; CANCER RADIOTHERAPY; CANCER STAGING; CANCER SURGERY; CANCER SURVIVAL; CANCER THERAPY; ELECTRON BEAM INTRAOPERATIVE RADIOTHERAPY; EXTERNAL BEAM RADIOTHERAPY; FEMALE; FIRST TRIMESTER PREGNANCY; GESTATIONAL AGE; HUMAN; IMMEDIATE BREAST RECONSTRUCTION; INTRAOPERATIVE RADIOTHERAPY; LOCOREGIONAL TREATMENT; LYMPHOSCINTIGRAPHY; MEDICAL DECISION MAKING; NONHUMAN; OUTCOME ASSESSMENT; PARTIAL BODY RADIATION; PARTIAL MASTECTOMY; PATIENT DECISION MAKING; PATIENT SAFETY; PREGNANCY OUTCOME; PREGNANCY TERMINATION; RADIATION DOSE; RADIATION EXPOSURE; REVIEW; SENTINEL LYMPH NODE BIOPSY; THERAPY DELAY; TREATMENT PLANNING;

EID: 84916880051     PISSN: 16132076     EISSN: 16132084     Source Type: Journal    
DOI: 10.1007/s10397-014-0860-6     Document Type: Review

References (44)

1. Azim HA Jr, Santoro L, Russell-Edu W, Pentheroudakis G, Pavlidis N, Peccatori FA (2012) Prognosis of pregnancy-associated breast cancer: a meta-analysis of 30 studies. Cancer Treat Rev 38(7):834–842
2. Ishida T, Yokoe T, Kasumi F et al (1992) Clinicopathologic characteristics and prognosis of breast cancer patients associated with pregnancy and lactation: analysis of case–control study in Japan. Jpn J Cancer Res 83:1143–1149
3. Anderson BO, Petrek JA, Byrd DR, Senie RT, Borgen PI (1996) Pregnancy influences breast cancer stage at diagnosis in women 30 years of age and younger. Ann Surg Oncol 3:204–211
4. Azim HA Jr, Botteri E, Renne G et al (2012) The biological features and prognosis of breast cancer diagnosed during pregnancy: a case–control study. Acta Oncol 51:653–661
5. Amant F, Loibl S, Neven P, Van Calsteren K (2012) Breast cancer in pregnancy. Lancet 379(9815):570–579
6. Amant F, Van Calsteren K, Halaska MJ, Gziri MM, Hui W, Lagae L, Willemsen MA, Kapusta L, Van Calster B, Wouters H, Heyns L, Han SN, Tomek V, Mertens L, Ottevanger PB (2012) Long-term cognitive and cardiac outcomes after prenatal exposure to chemotherapy in children aged 18 months or older: an observational study. Lancet Oncol 13(3):256–264
7. Amant F, von Minckwitz G, Han SN, Bontenbal M, Ring AE, Giermek J, Wildiers H, Fehm T, Linn SC, Schlehe B, Neven P, Westenend PJ, Müller V, Van Calsteren K, Rack B, Nekljudova V, Harbeck N, Untch M, Witteveen PO, Schwedler K, Thomssen C, Van Calster B, Loibl S (2013) Prognosis of women with primary breast cancer diagnosed during pregnancy: results from an international collaborative study. J Clin Oncol 31:2532–2539
8. Loibl S, Han SN, von Minckwitz G, Bontenbal M, Ring A, Giermek J, Fehm T, Van Calsteren K, Linn SC, Schlehe B, Gziri MM, Westenend PJ, Müller V, Heyns L, Rack B, Van Calster B, Harbeck N, Lenhard M, Halaska MJ, Kaufmann M, Nekljudova V, Amant F (2012) Treatment of breast cancer during pregnancy: an observational study. Lancet Oncol 13(9):887–896
9. Woo JC, Yu T, Hurd TC (2003) Breast cancer in pregnancy: a literature review. Arch Surg 138(1):91–98, discussion 99
10. Schwartz GF, Veronesi U, Clough K, Dixon JM, Fentiman IS, Heywang-Köbrunner SH, Holland R, Hughes KS, Margolese R, Olivotto IA, Palazzo JP, Solin LJ (2006) Proceedings of the Consensus Conference on Breast Conservation, April 28 to May 1, 2005, Milan, Italy Cancer; 107(2): 242–50
11. Amant F, Deckers S, Van Calsteren K, Loibl S, Halaska M, Brepoels L, Beijnen J, Cardoso F, Gentilini O, Lagae L, Mir O, Neven P, Ottevanger N, Pans S, Peccatori F, Rouzier R, Senn HJ, Struikmans H, Christiaens MR, Cameron D, Du Bois A (2010) Breast cancer in pregnancy: recommendations of an international consensus meeting. Eur J Cancer 46(18):3158–3168
12. Gentilini O, Masullo M, Rotmensz N et al (2005) Breast cancer diagnosed during pregnancy and lactation: biological features and treatment options. Eur J Surg Oncol 31:232–236
13. Berry DL, Theriault RL, Holmes FA et al (1999) Management of breast cancer during pregnancy using a standardized protocol. J Clin Oncol 17:855–861
14. Kuerer H, Gwyn K, Ames F et al (2002) Conservative surgery and chemotherapy for breast carcinoma during pregnancy. Surgery 131:108–110
15. Cardonick E, Iacubucci A (2004) Use of chemotherapy during pregnancy. Lancet Oncol 5:283–291
16. Duncan PG, Pope WDB, Cohen MM, Greer N (1986) Fetal risk of anesthesia and surgery during pregnancy. Anesthesiology 64:790–794
17. Vujovic O, Cherian A, Dar AR, Stitt L, Perera F (2006) Eleven-year follow up results in the delay of breast irradiation after conservative surgery in node-negative breast cancer patients. Int J Radiat Oncol Biol Phys 64(3):760–764
18. Hershman DL, Wang X, McBride R, Jacobson JS, Grann VR, Neugut AI (2006) Delay in initiating adjuvant radiotheraphy following breast conservation and its impact on survival. Int J Radiat Oncol Biol Phys 65(5):1353–1360
19. Chen Z, King W, Pearcey R, Kerba M, Mackillop WJ (2008) The relationship between waiting time for radiotherapy and outcome: a systematic review of the literature. Radiother Oncol 87:3–16
20. Mazonakis M, Varveris H, Damilakis J et al (2003) Radiation dose to conceptus resulting from tangential breast irradiation. Int J Radiat Oncol Biol Phys 55(2):386–391
21. International Commission on Radiological Protection (1991) Recommendations of the International Commission on Radiological Protection, ICRP Publication 60. Pergamon Press, Oxford
22. Kal HB, Struikmans H (2005) Radiotherapy during pregnancy: fact and fiction. Lancet Oncol 6(5):328–333
23. Han B, Bednarz B, Xu XG (2009) A study of the shielding used to reduce leakage and scattered radiation to the fetus in a pregnant patient treated with a 6-MV external X-ray beam. Health Phys 97(6):581–589
24. Van der Giessen PH (1997) Measurement of the peripheral dose for the tangential breast treatment technique with Co-60 gamma radiation and high energy X-rays. Radiother Oncol 42:257–264
25. Ngu SL, Duval P, Collins C (1992) Foetal radiation dose in radiotherapy for breast cancer. Australas Radiol 36:321–322
26. Antypas C, Sandilos P, Kouvaris J et al (1998) Fetal dose evaluation during breast cancer radiotherapy. Int J Radiat Oncol Biol Phys 40:995–999
27. Luis SA, Christie DR, Kaminski A et al (2009) Pregnancy and radiotherapy: management options for minimising risk, case series and comprehensive literature review. J Med Imaging Radiat Oncol 53(6):559–568
28. Kouvaris JR, Antypas CE, Sandilos PH, Plataniotis GA, Tympanides CN, Vlahos LJ (2000) Postoperative tailored radiotherapy for locally advanced breast carcinoma during pregnancy: a therapeutic dilemma. Am J Obstet Gynecol 183(2):498–499
29. Mulvihill JJ, McKeen EA, Rosner F, Zarrabi MH (1987) Pregnancy outcome in cancer patients. Experience in a large cooperative group. Cancer 60(5):1143–1150
30. Orecchia R, Leonardo MC (2011) Intraoperative radiation therapy: is it a standard now? Breast S3:S111–S115
31. NCC guidelines. http://www.nccn.org/professionals/physician_gls/PDF/breast.pdf
32. Galimberti V, Ciocca M, Leonardi MC et al (2009) Is electron beam intraoperative radiotherapy (ELIOT) safe in pregnant women with early breast cancer? In vivo dosimetry to assess fetal dose. Ann Surg Oncol 16(1):100–105
33. Morrow M et al (2009) Surgeon recommendations and receipt of mastectomy for treatment of breast cancer. JAMA 14:1551–1556
34. Al-Ghazal SK, Sully L, Fallowfield L, Blamey RW (2000) The psychological impact of immediate rather than delayed breast reconstruction. Eur J Surg Oncol 26:17–19
35. Fernandez-Delgado J, Lopez-Pedraza MJ, Blasco JA et al (2008) Satisfaction with and psychological impact of immediate and deferred breast reconstruction. Ann Oncol 19:1430–1434
36. Lohsiriwat V, Peccatori FA, Martella S, Azim HA Jr, Sarno MA, Galimberti V, De Lorenzi F, Intra M, Sangalli C, Rotmensz N, Pruneri G, Renne G, Schorr MC, Nevola Teixeira LF, Rietjens M, Giroda M, Gentilini O (2013) Immediate breast reconstruction with expander in pregnant breast cancer patients. Breast 22(5):657–660
37. Gentilini O, Cremonesi M, Trifiro G et al (2004) Safety of sentinel node biopsy in pregnant patients with breast cancer. Ann Oncol 15(9):1348–1351
38. Gentilini O, Cremonesi M, Toesca A et al (2010) Sentinel lymph node biopsy in pregnant patients with breast cancer. Eur J Nucl Med Mol Imaging 37(1):78–83
39. Du Bois A, Meerpohl HG, Gerner K et al (1993) Effect of pregnancy on the incidence and course of malignant diseases. Geburtshilfe Frauenheilkd 53(9):619–624
40. Morita ET, Chang J, Leong SP (2000) Principles and controversies in lymphoscintigraphy with emphasis on breast cancer. Surg Clin N Am 80:1721–1739
41. Russell JR, Stabin MG, Sparks RB, Watson E (1997) Radiation absorbed dose to the embryo/fetus from radiopharmaceuticals. Health Phys 73:756–769
42. Russell JR, Stabin MG, Sparks RB (1997) Placental transfer of radiopharmaceuticals and dosimetry in pregnancy. Health Phys 73:747–755
43. Khera SY, Kiluk JV, Hasson DM et al (2008) Pregnancy-associated breast cancer patients can safely undergo lymphatic mapping. Breast J 14(3):250–254
44. Pandit-Taskar N, Dauer LT, Montgomery L, Germain SJ, Zanzonico PB, Divgi CR (2006) Organ and fetal absorbed dose estimates from 99 mTc-sulfur colloid lymphoscintigraphy and sentinel node localization in breast cancer patients. J Nucl Med 47:1202–1208